GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Change In Other Working Capital

Yumanity Therapeutics (FRA:8IY) Change In Other Working Capital : €-3.34 Mil (TTM As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Change In Other Working Capital?

Yumanity Therapeutics's Change In Other Working Capital for the quarter that ended in Sep. 2022 was €-1.78 Mil. It means Yumanity Therapeutics's Other Working Capital declined by €1.78 Mil from Jun. 2022 to Sep. 2022 .

Yumanity Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2021 was €-6.65 Mil. It means Yumanity Therapeutics's Other Working Capital declined by €6.65 Mil from Dec. 2020 to Dec. 2021 .

Yumanity Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Yumanity Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Change In Other Working Capital Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Change In Other Working Capital
-0.89 5.27 -6.65

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.36 2.72 -5.26 0.98 -1.78

Yumanity Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yumanity Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Change In Other Working Capital
Comparable Companies
CYTO ALNA BRTX KTRA ADTX STAB NBRV PSTV CYCC LEXX OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Website
https://www.yumanity.com
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines